Your browser doesn't support javascript.
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Wall, Emma C; Wu, Mary; Harvey, Ruth; Kelly, Gavin; Warchal, Scott; Sawyer, Chelsea; Daniels, Rodney; Adams, Lorin; Hobson, Philip; Hatipoglu, Emine; Ngai, Yenting; Hussain, Saira; Ambrose, Karen; Hindmarsh, Steve; Beale, Rupert; Riddell, Andrew; Gamblin, Steve; Howell, Michael; Kassiotis, George; Libri, Vincenzo; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Bauer, David Lv.
  • Wall EC; Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
  • Wu M; Francis Crick Institute, London NW1 1AT, UK.
  • Harvey R; Francis Crick Institute, London NW1 1AT, UK.
  • Kelly G; Francis Crick Institute, London NW1 1AT, UK.
  • Warchal S; Francis Crick Institute, London NW1 1AT, UK.
  • Sawyer C; Francis Crick Institute, London NW1 1AT, UK.
  • Daniels R; Francis Crick Institute, London NW1 1AT, UK.
  • Adams L; Francis Crick Institute, London NW1 1AT, UK.
  • Hobson P; Francis Crick Institute, London NW1 1AT, UK.
  • Hatipoglu E; University College London, London, UK.
  • Ngai Y; University College London, London, UK.
  • Hussain S; Francis Crick Institute, London NW1 1AT, UK.
  • Ambrose K; Francis Crick Institute, London NW1 1AT, UK.
  • Hindmarsh S; Francis Crick Institute, London NW1 1AT, UK.
  • Beale R; Francis Crick Institute, London NW1 1AT, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Riddell A; Francis Crick Institute, London NW1 1AT, UK.
  • Gamblin S; Francis Crick Institute, London NW1 1AT, UK.
  • Howell M; Francis Crick Institute, London NW1 1AT, UK.
  • Kassiotis G; Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Swanton C; Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Gandhi S; Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Bauer DL; Francis Crick Institute, London NW1 1AT, UK. Electronic address: david.bauer@crick.ac.uk.
Lancet ; 398(10296): 207-209, 2021 07 17.
Article in English | MEDLINE | ID: covidwho-1284623
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Adult / Humans / Middle aged Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01462-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Adult / Humans / Middle aged Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)01462-8